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8 General introduction 
 
‘Some 2.4 billion years ago, photosynthesis lead to the accumulation of oxygen 
to levels that were likely toxic to many obligate anaerobes. Organisms that could 
defend themselves against oxidative stress, and at the same time utilize oxygen 
for energy, survived and evolved. As time went on, a cellular requirement for 
oxygen became critical, and animals developed a biochemical response to low 
levels of oxygen.’ 
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General introduction 
The fetal circulation 
Fetal cardiac development starts in the third week of gestation.2 Innervation of 
the heart occurs at five weeks and by eight weeks it has developed into a four-
chambered system resembling the adult heart.2 Throughout gestation the heart 
continues to grow and adapt to increasing hemodynamic demands.3 Lung 
development starts at four weeks gestational age.4 The formation of sacculi from 
the terminal bronchioles with a first primitive air-blood-barrier, however, only 
begins at about 24 weeks gestational age, which limits effective ventilation of 
those born earlier.4 By 32 weeks, septation of the terminal sacs begins along with 
maturation of the surfactant system and capillary network and by 36 weeks the 
first true thin-walled alveoli responsible for effective gas exchange are visible.4  
Until birth, the fetal lungs are filled with amniotic fluid and the fetus depends on 
oxygen and nutrient supply via the placenta. Therefore, the fetal circulation has to 
be different from the postnatal circulation. In short, highly oxygenated blood from 
the placenta is transported through the umbilical vein towards the liver. Half of 
the oxygenated blood is shunted away from the liver towards the heart through 
the ductus venosus.2,5 Although it mixes with de-oxygenated blood returning from 
fetal body parts into the vena cava, most of the oxygenated blood is directed 
towards the left atrium.2,5 From here, it follows the pressure gradient into the 
right atrium through a second shunt, the foramen ovale.2,5 Bypassing the right 
ventricle and lungs, well-oxygenated blood is thus directly shunted towards the 
left ventricle, which supplies the brain, heart, and upper limbs.2,5 Before 
descending further towards the lower fetal body parts, remaining blood mixes 
with less-oxygenated blood from the right ventricle, which has bypassed the 
pulmonary circulation through a third shunt, the ductus arteriosus, facilitated by a 
high pulmonary vascular resistance.2,5 A substantial fraction of the mixed blood 
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returns to the placenta via the umbilical arteries, while the remainder supplies the 
lower fetal body parts and abdominal viscera.5,6 
Fetal neurodevelopment 
Brain development begins during week four of gestation with the formation of a 
forebrain (primary prosencephalon), midbrain (mesencephalon), and hindbrain 
(rhombencephalon) from the neural tube.7 The forebrain separates into the 
diencephalon and the secondary prosencephalon.8 While the former will give rise 
to the thalamus and epithalamus, the latter will develop into hypothalamus, 
retina, and telencephalon comprising cerebral cortex, hippocampus, and basal 
ganglia.8,9 The mesencephalon does not further subdivide but comprises the most 
cranial part of the brainstem.8 The medulla and pons of the brainstem and the 
cerebellum will develop from the hindbrain, from which also the spinal cord will 
extend.8  
Brain development is initiated by rapid proliferation of neuronal precursor cells 
within the (periventricular) germinal matrix, which begin to differentiate at eight 
weeks gestation and subsequently migrate to their destined location.7 This results 
in growth and increased folding of the cortex.10 Following migration, which is 
completed at approximately 29 weeks gestation, the neurons start to synapse.7 A 
prominent role in this process plays brain-derived neurotrophic factor (BDNF), 
expression of which is dependent on neuronal activity.11,12 Established neural 
circuits are quickly stabilized by myelination of neuronal axons visible as white 
matter.7 Synaptogenesis and myelination continue long into adolescence and 
interruption can cause severe neurodevelopmental impairment.7  
Vascularization of the brain 
The brain derives its blood supply via the internal carotid and subclavian arteries, 
which gain their familiar morphology by seven weeks gestational age.2 The first 
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branches into the anterior, middle, and posterior cerebral arteries (ACA, MCA, and 
PCA, respectively), which supply the cerebral hemispheres.13 The latter gives rise 
to the vertebral arteries, which join to become the basilar artery, supplying 
brainstem and cerebellum.13 A connection between the PCA and basilar artery 
develops, forming an anastomosis between the two vascular systems (the ‘Circle 
of Willis’), while the carotid origin of the PCA regresses.14,15 Vascularization of the 
retina occurs only by the final trimester after maturation of the lens and 
regression of the hyaloid artery from lens to retina. 9,16 This artery is later known 
as the central artery of the retina and constitutes a branch of the ophthalmic 
artery, which originates from the internal carotid.9  
Intracerebral microvascularization develops early from the perineural 
(extracerebral) vascular plexus, from where capillaries penetrate deep into the 
brain tissue by angiogenic mechanisms, establishing an anastomotic plexus at the 
subventricular zone.17-19 From here, the brain parenchyma is vascularized in an 
ascending fashion, continuously reshaping according to neurodevelopmental 
needs, not to be complete within cortical areas until the age of 4 years.17,20,21 This 
angiogenic process is driven by vascular endothelial growth factor (VEGF), which 
also promotes survival of neurons and glial cells and axonal outgrowth.22 
Interaction between the vascular endothelium and parenchymal astrocytes results 
in the formation of a blood-brain barrier (BBB), which limits the cerebral 
permeability to circulating cells or particles and safeguards cerebral extracellular 
homeostasis.23 Maturation of the BBB is not complete until a few weeks after 
term.21,24  
An important feature of the brain is cerebrovascular autoregulation. It is the 
ability of the brain to preserve adequate cerebral perfusion despite fluctuations in 
blood pressure and oxygenation.25 Functionality of adaptive vasodilation and 
constriction depends on the maturation of neurovascular mechanisms, which 
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starts at 23 weeks gestational age and is not yet fully established at term.19,21 
Impairment of the cerebral autoregulation may cause cerebral ischemia and 
hemorrhage.26 
Fetal growth restriction 
Fetal growth restriction (FGR) is a condition defined as fetal growth below its 
constitutional growth potential and is therefore not to be used interchangeably 
with being small-for-gestational age, which also includes fetuses or neonates 
being constitutionally small.27 FGR may be caused by chromosomal or genetic 
syndromes, multiple gestation, congenital infection or metabolic disease, drug 
use, or inadequate maternal nutrition, but most common is placental insufficiency 
associated with gestational hypertension, preeclampsia (PE), diabetes, smoking, 
or other forms of abnormal uteroplacental development.28,29 Moreover, there 
seems to be a difference in placental pathology relative to onset of fetal growth 
restriction, with the placentas of early-onset fetal growth restriction (before 
approximately 32 weeks gestational age at diagnosis) showing more histologic 
signs of maternal vascular (uteroplacental) underperfusion, while late-onset fetal 
growth restriction is more associated with fetoplacental (villous) lesions.30,31 
Placental insufficiency and fetal hemodynamic redistribution 
The placenta is the organ that supplies the fetus with oxygen and nutrients and 
removes waste back to the maternal circulation.32 Development of the placenta 
starts with the invasion of trophoblasts, the outer cell layer of the embryonic 
blastocyst, into the maternal endometrium and its capillary network.33 This results 
in the formation of large sinuses, the so-called intervillous space, where exchange 
of gas and metabolites takes place.33 The spiral arteries, which originate from the 
uterine arteries and supply the endometrium, are being remodeled and lose their 
smooth muscle layer, which turns them into highly dilated vessels with low 
GI
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vascular resistance.34 Fetal trophoblasts further bulge into the intervillous space 
to form the chorionic (‘anchoring’) villi, which develop an extensive network of 
capillaries connecting to the fetal umbilical veins.35 
Impaired remodeling of the spiral arteries is seen in early-onset PE.36 Failure of 
dilation causes high jet velocities and high perfusion pressure in the intervillous 
space, which is damaging to chorionic villi and decreases the fetal capillary 
network.34,37 High uteroplacental resistance subsequently results in reduced 
placental perfusion and fetal hypoxia on the one hand and maternal hypertension 
and organ damage on the other.34,36 Although the pathophysiology of PE is much 
more complex and not yet fully understood, impaired placental perfusion can be 
detected during prenatal Doppler ultrasound as an increased resistance in the 
umbilical artery (UA), which normally decreases with progression of pregnancy.38 
As a compensatory response to hypoxia, the fetus redistributes its cardiac output 
with preferential perfusion of the brain at the expense of the systemic 
perfusion.39 Whether this is neuroprotective and an active fetal mechanism is still 
controversial.40,41 However, this so-called ‘brain-sparing’ effect becomes apparent 
on prenatal Doppler as a decrease in resistance of the fetal MCA following 
cerebral vasodilation.42 Moreover, with progressive hypoxia, intracerebral 
regional redistribution seems to occur from higher towards lower order brain 
functions as the fetus starts to decompensate.43-45 Postnatally, body size of FGR 
infants with fetal brain-sparing may be asymmetric with a disproportionately large 
head (although still too small for gestational age) relative to body weight.40 
There has been much interest in the prevention and therapy of placental 
insufficiency. Promising options include oral phosphodiesterase 5 (PDE-5) 
inhibitors and local injections increasing placental VEGF expression.46,47 However, 
up to date, no effective and safe treatment of placental insufficiency exists and 
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FGR remains associated with a high risk of perinatal death and (iatrogenic) 
preterm birth.47  
Preterm birth 
Preterm birth is defined as birth before 37 weeks gestational age and its 
complications are the leading cause of global childhood mortality under five years 
of age.48 In Europe, about 9% of all live births are preterm and of these, 15% occur 
before 32 weeks’ gestation.49 Well known causes of preterm birth comprise 
placental insufficiency and fetal growth restriction, maternal respiratory and 
urinary infections, abnormal placentation, cervical insufficiency, ascending 
intrauterine infection, and/or congenital anomalies.50-52 Further risk factors 
include multiple pregnancy, maternal stress and nutritional status, substance 
abuse, and genetic predisposition.53 However, the majority of preterm births will 
be classified as idiopathic as no identifiable reason can be found. 
Postnatal hemodynamics 
With birth, the fetus enters a transitional phase, in which it adapts to postnatal 
life. It starts with the first breath and inflation of the lungs, which instantly lowers 
the pulmonary vascular resistance and increases pulmonary perfusion by the right 
ventricle.54 Fetal lung fluid is absorbed and enters blood plasma increasing the 
circulating volume.54 (Early) clamping of the umbilical cord results in a sudden 
decrease in preload and increase in afterload to which cardiac contractility and 
output have to adapt.55,56 Preload gradually increases with improved ventilation 
and increased left atrial return from the lungs.57 Cardiac remodeling towards left 
ventricular predominance begins.57 Within hours to days, the ductus arteriosus, 
foramen ovale, and ductus venosus close.58,59  
These sudden hemodynamic changes are particularly challenging for preterm 
and FGR neonates, which usually need ventilatory and sometimes hemodynamic 
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support. The neonatal lungs may struggle with the clearance of amniotic fluid and 
inflation due to immaturity of sodium channels, cesarean delivery, and surfactant 
deficiency.60 The heart has a reduced ability to increase contractility and output to 
maintain adequate perfusion. This may be associated with an immature 
myocardium in the preterm infant or a decreased cardiac reserve following FGR-
associated compensatory cardiac adaptation to intrauterine hypoxia.61-64 Perinatal 
asphyxia (oxygen deprivation) as it may occur with placental insufficiency, may 
further depress cardiac function.64 A depressed cortisol and catecholamine surge 
due to cesarean delivery and/or immature adrenal glands further contributes to 
postnatal hypotension and ineffective clearance of lung fluid.60 Moreover, the 
ductus arteriosus may fail to close, causing decreased systemic perfusion and 
pulmonary hypertension as blood is now shunted into the opposite direction, 
namely from the aortic arch back into the pulmonary vasculature.5 While any 
fluctuations in perfusion pressure and oxygenation especially affect organs with 
less effective autoregulation, such as the intestines or kidneys, cerebral 
autoregulation should spare the brain.65 However, cerebral autoregulation in 
preterm FGR neonates is frequently impaired, which relates to a combination of 
immaturity, asphyxia-associated vasoparalysis, and overriding brain-sparing 
mechanisms.66,67 Sickness and maternal or neonatal medication may further 
interfere with autoregulation and stable cerebral hemodynamics.68-71 
Outcomes associated with preterm birth and FGR 
Neonatal complications of preterm birth and/or FGR are manifold and largely 
associated with organ immaturity and underlying pathology.72 They include 
respiratory distress, bronchopulmonary dysplasia (BPD), persistent pulmonary 
hypertension (PPHN), a patent ductus arteriosus (PDA), necrotizing enterocolitis 
(NEC), hypoglycemia, hyperbilirubinemia, anemia, sepsis, peri- and 
intraventricular hemorrhage (PIVH), periventricular leukomalacia (PVL), and 
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retinopathy of prematurity (ROP).73-76 In The Netherlands, the survival rate for 
neonates born before 24 weeks gestational age is less than 10%, but with active 
intervention from 24.0 weeks onwards rises to about 60% at 24.0 weeks and 
almost 100% by 32.0 weeks of gestation.77 Although advanced perinatal care has 
led to improved outcomes of preterm infants, survival without major morbidity, in 
particular of those born extremely preterm, remains a challenge.78-80 Moreover, 
there is an increased risk for chronic kidney disease, metabolic syndrome, 
cardiovascular disease, and neurodevelopmental problems in later life, 
particularly in those born following FGR.81-85 
Brain injury  and neurodevelopmental abnormalities after preterm birth and FGR 
Preterm birth has been associated with altered regional brain volumes. Major risk 
factors are white matter injury, which presents a loss of myelinating 
oligodendrocytes associated with hypoxia- or inflammation-induced 
excitotoxicity, and FGR.86,87 Structural abnormalities associated with FGR likely 
reflect regional hemodynamic redistribution and include reduced cortical, 
hippocampal, and cerebellar volume, altered vascularization, delayed myelination, 
reduced synapsing in pre-frontal or limbic systems, and impaired neuronal 
migration.88 Accordingly, preterm and FGR infants more often struggle with 
abnormal neurodevelopmental outcomes than term and appropriate-for-
gestational age infants. These include cerebral palsy or minor motor impairments, 
epilepsy, sensory impairments, cognitive deficits, behavioral abnormalities, 
attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), 
and language difficulties.89-91 Impairments may become apparent as minor 
academic difficulties but can also be severely disabling.92  
Assessment of brain damage is therefore routinely performed in preterm and 
FGR infants. Serial cranial ultrasound can effectively detect PIVH and PVL 
(ischemia of the white matter at the watershed zones around the lateral 
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ventricles), while magnetic resonance imaging is better in detecting cerebellar 
hemorrhage or mild white matter injury.93,94 (Amplitude-integrated) 
electroencephalography can further aid in the prediction of white matter damage-
associated neurological outcome and assessment of the variability and complexity 
of the early motor repertoire (general movements) may predict motor 
abnormalities and cognitive dysfunction.95-98 
Hypoxic brain injury 
As one may expect, hypoxia plays a pivotal role in brain injury. Hypoxemia 
disturbs mitochondrial adenosine triphosphate (ATP) generation and 
consequently ATP-dependent maintenance of an electrochemical gradient across 
the cell-membrane.99 In addition to cellular edema, this causes decreased uptake 
of extracellular glutamate by astrocytes and increased glutamate release by 
neurons.99 Excess glutamate in turn overactivates synaptic and extrasynaptic 
glutamate receptors, which causes excess calcium influx and induces pro-
apoptotic pathways.100 Moreover, excessive calcium within the mitochondria 
enhances mitochondrial generation of harmful reactive oxygen species 
(ROS).101,102 This production of ROS requires oxygen, which explains an additional 
oxidative tissue injury by ROS upon reperfusion.101 In addition, microglial 
overactivation by glutamate causes disruption of the BBB and 
neuroinflammation.103 However, a glutamate imbalance seems to be particularly 
harmful to immature oligodendrocytes, which express higher levels of glutamate 
receptors than mature oligodendrocyte.104,105 Prenatal magnesium sulfate 
(MgSO4) intravenously administered before imminent preterm birth has shown to 
protect the immature brain from excitotoxic injury by blockade of glutamate 
receptors, which has shown to effectively decrease the risk of cerebral 
palsy.100,106,107 Since moderate hypoxia is necessary for early embryonic and fetal 
(neuro)development, hypoxia may be especially harmful in advancing gestational 
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age where metabolic demands increase.108 However, if oxygen saturations are too 
low in early gestation this may disturb critical developmental processes, such as 
neuronal migration and synaptogenesis as outlined earlier.108 
Hyperoxic brain injury 
Hyperoxia has also demonstrated to be harmful to immature brain tissue and has 
been associated with reduced synaptic plasticity and myelination.109 While the 
fetal brain develops well at relatively low arterial oxygen tensions of about 25 mm 
Hg, slowly increasing until term, oxygen tension quickly rises to about 70 mm Hg 
following birth.109,110 A consequential increase in ROS generation from an oxygen-
rich environment cannot be effectively counterbalanced until maturation of the 
antioxidant defense in the third trimester.109 Thereby hyperoxia is particularly 
harmful at low gestational age and preterm birth. As ROS react with various kinds 
of molecules, oxidative stress may damage DNA and mitochondrial membranes 
and eventually induces apoptosis.111 Moreover, ROS production seems to be 
especially high in motor neurons and disturb adjacent astrocytic glutamate 
reuptake.112 In addition, ROS cause lipid peroxidation, which disrupts the myelin 
sheath.109,113 Damage is potentiated, if hyperoxia is preceded by hypoxia-induced 
excitotoxic damage, which commonly occurs with placental insufficiency or 
immaturity-associated hemodynamic fluctuations.109  
Alterations in gene expression and methylation by hypo- and hyperoxia 
In addition to direct cell injury, hypo- and hyperoxia may also interfere with the 
expression of genes important for normal maturation and neurodevelopment. In 
the brain, this has become particularly evident for retinal tissue, in which a 
sudden rise in oxygen tension following preterm birth results in downregulation of 
VEGF and angiogenesis.114 Reduced retinal vascularization in turn leads to retinal 
hypoxia as the retina matures, upon which uncontrolled upregulation of VEGF and 
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angiogenesis result in the formation of tortuous, leaky vessels, hemorrhage, and 
in severe cases detachment of the retina and blindness.114 In the postnatal period, 
arterial oxygen saturation (SaO2) is therefore kept within a narrow moderately-
high range to reduce hyperoxic exposure and the incidence of ROP without 
increasing the risk of hypoxia, NEC, and mortality.115  
The transcription factor hypoxia-inducible factor 1 (HIF1) is a key regulator of 
the hypoxic response, although other factors such as cAMP response element 
binding protein (CREB) also appear to be involved.116 The alpha-subunit of HIF1 
stabilizes in response to low oxygen concentrations, dimerizes with its beta-
subunit and binds to the hypoxia-response element (HRE) in the promotor region 
of its target genes.116 The most popular target genes include VEGF and 
erythropoietin (EPO), which stimulate angiogenesis and the production of 
erythrocytes, respectively, alongside neurotrophic functions.22,117 In addition, 
hypoxia is able to induce epigenetic modifications, which act in concert with HIF1, 
and thereby long-term alterations in genetic expression, which has been 
implicated as an important component of embryogenesis, neurodevelopment, 
and disease.116,118,119 Indeed, several neurodevelopmental disorders, such as 
schizophrenia and autism, have been linked to hypoxia and the downregulation of 
VEGF and glutamate receptor units.120 Moreover, experimental studies have 
shown that deletion of the HRE region in the VEGF gene causes motor neuron 
degeneration and that hyperoxia in neonatal mice reduces the expression of 
BDNF, underlining the regulatory role of oxygen in neurodevelopment.121,122  
Monitoring tissue oxygenation with near-infrared spectroscopy 
Postnatal regional tissue oxygen saturation (rSO2) can non-invasively be measured 
in the neonate using near-infrared spectroscopy (NIRS). Several devices exist, but 
here we will only address the INVOS device as used at our neonatal intensive care 
unit. Its technology utilizes tissue translucency to near-infrared light at a 
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wavelength spectrum of 730-810 nm, which is differentially absorbed by 
oxygenated and de-oxygenated hemoglobin and maximally separated from the 
absorption spectrum of water, preventing its interference.123 Melanin, a pigment 
found in hair and skin, and bilirubin, a breakdown product of heme present in the 
skin with neonatal icterus, also well absorb light within the same wavelengths, 
which can lower rSO2 measurements and produce outliers.
124 However, 
directional changes in rSO2 remain visible, allowing for adequate trend 
monitoring.125 
Near-infrared light is delivered to the tissue by an emitting diode located 
within the sensor placed on the skin above the tissue of interest. Unabsorbed light 
is reflected and detected by two optodes located next to each other on the same 
sensor, as visualized in Figure 1. The signal returning to the optode situated closer 
to the light source is subtracted from the signal returning to the optode further 
away, thereby reducing signals from superficial tissue such as skin and bone.126  
 
Figure 1. Monitoring (cerebral) tissue oxygenation with near-infrared spectroscopy. 
Adopted from Zaleski et al.
127 
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In contrast to pulse oximetry, which subtracts non-pulsatile flow measurements 
to be able to measure only arterial oxygen saturation, NIRS measures reflections 
from the whole tissue microcirculation.128 As the venous bed is largest, rSO2 
largely reflects venous oxygenation.129 Simultaneous use of NIRS and pulse 
oximetry therefore allows calculation of the fractional tissue oxygen extraction 
(FTOE) using the formula FTOE = (SaO2 – rSO2)/SaO2, which is an indicator of tissue 
ischemia, as it reflects the balance between oxygen delivery and consumption.130  
NIRS is becoming increasingly popular in neonatal intensive care, although its 
clinical use and interpretation remains subject of extensive research.131 Cerebral 
NIRS has demonstrated to be of particular value in preterm and FGR infants as it 
visualizes changes in cerebral perfusion associated with cardiorespiratory 
immaturity and transitional complications.132 Simultaneous monitoring of the 
splanchnic and renal tissue can be useful to early detect and interpret changes in 
global oxygenation status.133 Figure 2 depicts the typical sites for NIRS monitoring 
in the neonate. Moreover, multisite NIRS can reflect fetal hemodynamic 
redistribution and brain-sparing associated with FGR, which may persist for 
several days after birth.134  
Cerebral oxygenation in the detection of brain injury 
In newborn piglets, a cerebral rSO2 below 35% has been associated with ischemic 
tissue damage and abnormal cerebral function, although this value may vary with 
different types of sensors.135,136 Likewise, a high cerebral FTOE, reflecting tissue 
hypoxia either due to increased cerebral perfusion or decreased cerebral 
metabolism, has been associated with a higher risk of PVL.137 Its association with 
PIVH is less straightforward, as the pathophysiology of PIVH involves initial 
hyperperfusion and subsequent hypoperfusion.138,139 Assessing the correlation 
between cerebral rSO2 and blood pressure can, however, detect impairment of 
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cerebral autoregulation, predict the risk of PIVH and PVL, and may aid in 
hemodynamic therapy.140  
Figure 2. Sensor locations in cerebral, splanchnic, and renal near-infrared spectroscopy 
(NIRS). 
 
Although gestational age-associated reference values for cerebral rSO2 and 
FTOE have been determined for the postnatal period and attempts have already 
been made to reduce the cerebral hypo- and hyperoxic exposure, optimal 
saturation ranges in relation to brain development and function remain 
unknown.141-144 To effectively interpret and address cerebral oxygenation in 
preterm and FGR infants and improve neurologic outcome, we first need to better 
define and comprehend cerebral normoxia and how it relates to perinatal 
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Aims and outline of this thesis 
Given the high vulnerability of the brain and hemodynamic system in preterm and 
FGR neonates during the perinatal period, this thesis aims to contribute to an 
improved understanding of the perinatal cerebral and systemic tissue 
oxygenation, including fetal brain-sparing, and associated neurodevelopmental 
outcome in this patient population. 
Part I of this thesis deals with the influence of prenatal medication and placental 
dysfunction on the cerebral and systemic tissue oxygenation of the preterm 
and/or FGR infant. The following research questions will be answered:  
Chapter 1: Do maternal medications with antihypertensive properties, such as 
labetalol, nifedipine, and MgSO4 affect the cerebral, renal, and splanchnic tissue 
oxygenation of preterm infants? 
Chapter 2: Are changes in postnatal cerebral tissue oxygenation following 
prenatal MgSO4 exposure related to changes in cerebral metabolism or perfusion 
and can they be differentiated from underlying hemodynamic effects of PE and 
fetal brain-sparing? 
Chapter 3: Does prenatal sildenafil treatment for severe-early onset FGR affect 
postnatal cerebral and renal tissue oxygenation?  
Part II of this thesis will address neurologic outcomes of fetal brain-sparing and 
postnatal cerebral tissue oxygen saturation. The following research questions will 
be answered: 
Chapter 4: Is a prolonged duration of cerebral hyperoxia associated with the 
development of severe retinopathy of prematurity?  
Chapter 5: How do fetal brain-sparing and postnatal cerebral oxygenation 
relate to intelligence, behavior, and executive functioning at 4 years of age in 
children born following FGR? 
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Chapter 6: Is fetal brain-sparing in FGR associated with differential oxygen-
dependent methylation of neuroprotective genes at 4 years of age? 
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